Thus, we knocked down TTN-AS1 expression by using shRNA#1 and shRNA#2, and assessed the tumor cell migration and invasion abilities with wound-healing assays, as well as transwell migration and invasion assays. The gene discussed is TTN; the disease is neoplasm.